NEOPLASMS, COLON
Clinical trials for NEOPLASMS, COLON explained in plain language.
Never miss a new study
Get alerted when new NEOPLASMS, COLON trials appear
Sign up with your email to follow new studies for NEOPLASMS, COLON, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy showdown: could dostarlimab replace chemo for some colon cancers?
Disease control Recruiting nowThis study tests whether the immunotherapy drug dostarlimab, given before and after surgery, works better than standard treatments for people with a specific type of colon cancer (dMMR/MSI-H) that has not spread. About 892 participants will be randomly assigned to receive either …
Matched conditions: NEOPLASMS, COLON
Phase: PHASE3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated May 17, 2026 04:31 UTC
-
New drug combo shows promise in colon cancer fight
Disease control Recruiting nowThis study tests whether adding the drug dostarlimab to standard chemotherapy (CAPEOX) before surgery works better than chemotherapy alone for a common type of colon cancer. About 120 people with stage III or T4N0 colon cancer that has normal DNA repair will take part. The goal i…
Matched conditions: NEOPLASMS, COLON
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated May 17, 2026 04:28 UTC